Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rociletinib
rociletinib
Clovis Oncology to Pay the SEC $20 Million for Misleading Investors
BioSpace
Wed, 09/19/18 - 11:29 am
Clovis Oncology
SEC
investors
lung cancer
rociletinib
Clovis writes a $20 million check payable to the SEC, hoping to rid itself of the lingering roci probe
Endpoints
Thu, 08/2/18 - 11:20 pm
Clovis Oncology
SEC
rociletinib
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Motley Fool
Sun, 12/4/16 - 12:37 pm
biotech
Alnylam
revusiran
Clovis Oncology
rociletinib
Celldex Therapeutics
Rintega
Eli Lilly
solanezumab
Novavax
RSV-F
Arrowhead
ARC-520
ARC-521
ARC-AAT
Biomarin
drisapersen
3 Shocking Biotech Flops of 2016 So Far
Motley Fool
Fri, 07/8/16 - 11:01 am
biotech
Rintega
Celldex Therapeutics
glioblastoma
Clovis Oncology
rociletinib
lung cancer
NewLink Genetics
algenpantucel-L
pancreatic cancer
2 FDA Decisions To Watch In June
Seeking Alpha
Wed, 06/1/16 - 10:54 am
FDA
rociletinib
Clovis Oncology
KemPharm
Apadaz
After shutting down cancer drug, Clovis now facing government investigations
BioPharma Dive
Fri, 05/13/16 - 10:15 am
Clovis Oncology
rociletinib
FDA
Clovis shuts down cancer drug, will reduce staff by 35%
BioPharma Dive
Sat, 05/7/16 - 01:17 pm
Clovis Oncology
rociletinib
layoffs
Are Analysts Realistic on Clovis Oncology Now?
24/7 Wall St
Sun, 04/17/16 - 11:18 am
Clovis Oncology
rociletinib
Clovis Lung Cancer Drug Trashed at FDA Panel, CEO Exit Next?
TheStreet.com
Tue, 04/12/16 - 03:43 pm
Clovis Oncology
FDA
advisory panels
rociletinib
Pat Mahaffy
FDA staff questions Clovis drug's benefit over current treatments
Yahoo/Reuters
Fri, 04/8/16 - 11:08 am
FDA
Clovis Oncology
rociletinib
non-small cell lung cancer
Struggling Clovis to once again chase FDA favor for would-be Tagrisso competitor
BioPharma Dive
Tue, 02/16/16 - 10:26 am
Clovis Oncology
FDA
Tagrisso
rociletinib
3 Upcoming FDA Decisions We're Most Excited About
Motley Fool
Sat, 02/13/16 - 09:25 am
FDA
Acadia
Intercept Pharma
Clovis Oncology
Nuplazid
OCA
rociletinib
Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12
Yahoo/Benzinga
Fri, 02/12/16 - 04:25 pm
Clovis Oncology
rociletinib
FDA
non-small cell lung cancer
4 Pharmaceutical Stocks With Big Catalysts Pending in 2016
24/7 Wall St
Fri, 01/8/16 - 09:43 am
Jazz Pharmaceuticals
Defibrotide
Clovis Oncology
rociletinib
Insys
Dronabinol
Gilead Sciences
F/TAF
Clovis Oncology: The Revenant?
Investopedia
Wed, 12/16/15 - 07:59 pm
rociletinib
Clovis Oncology
Clovis Oncology's Loss Could Be a Win for AstraZeneca
Motley Fool
Thu, 11/19/15 - 09:47 am
Clovis Oncology
AstraZeneca
rociletinib
Tagrisso
non-small cell lung cancer
The FDA asked this company for some data and now its stock is down 72%
Yahoo/Business Insider
Mon, 11/16/15 - 03:31 pm
Clovis Oncology
FDA
rociletinib
Clovis Oncology Gets Hit Hard: FDA Delays Approval
Bidness, ETC
Mon, 11/16/15 - 09:18 am
Clovis Oncology
FDA
rociletinib
non-small cell lung cancer
3 Cancer Companies to Watch Closely in 2016
Motley Fool
Tue, 10/20/15 - 10:00 am
cancer
Celldex
Medivation
Clovis Oncology
rociletinib
talazoparib
Rintega
Clovis Oncology Inc Giving AstraZeneca plc A Hard Time In Cancer
Bidness, ETC
Fri, 10/2/15 - 09:11 am
Clovis Oncology
AstraZeneca
rociletinib
AZD9291
non-small cell lung cancer
Pages
1
2
next ›
last »